Bidirectional cell transfer during pregnancy frequently leads to post-partum persistence of allogeneic cells and allo immune responses in both the mother and in her offspring. 
INTRODUCTION
Mismatches between the Human Leukocyte Antigen (HLA) haploidentical mother and child may lead to mutual priming of allo immune cells. Although pregnancy frequently results in activation of maternal B cells 1 and T CTL directed against fetal Inherited Paternal Alloantigen (IPA), such as HLA 2 and minor H antigens 3 , not all parous women develop cytolytic activity against the latter alloantigens 3
. Importantly, long-lasting tolerance may also be induced in offspring exposed to Non-Inherited Maternal Alloantigen (NIMA) such as Rhesus D 4 or HLA 5 . The latter is illustrated by a failure to generate allo antibodies after re exposure to the relevant alloantigens through pregnancy 4 or through multiple blood transfusions 5 .
The immunological mechanism(s) involved in these apparent states of naturally acquired allo tolerance is still poorly understood. The presence of fetal or maternal microchimeric cells may play a role in the induction and/or maintenance of a tolerant status 6 . There is ample evidence for a mutual exchange of mature blood and progenitor cells between the mother and her fetus. While mature blood cells have a limited lifespan, hematopoietic stem cells 7 and HLA dim mesenchymal stem cells 8 may engraft in the bone marrow, where they remain throughout life. Cells obviously derived from fetal hematopoietic progenitor cells can be detected in the maternal circulation up to several decades after the delivery 9 . Likewise, hematopoietic 6;10 and non-hematopoietic 11 cells from maternal origin may persist into adulthood. The tolerogenic potential of chimerism, established either through bone marrow transplantation (macrochimerism) 12 or through pregnancy (microchimerism) 7 , has been documented in both rodent 13;14 and in human transplant settings 15;16 .
We earlier described the presence of minor H antigen HA-1 specific T CTL , minor H antigen HA-1 specific T REG and HA-1 pos circulating microchimeric cells in the setting of kidney transplantation 17 . The latter cell populations were observed in a long term tolerant HA-1 neg patient transplanted with a renal allograft from her HLA identical HA-1 pos sister.
These T CTL and T REG could be physically separated based on differences in their capacity to bind HLA-A2/minor H peptide tetramers. While HA-1 tetramer bright staining T cells were found to mediate delayed type hypersensitivity reactions and produced IFNγ in response to HA-1 allo peptide, their function was suppressed in the presence of TGFβ and IL-10 producing HA-1 tetramer dim staining T cells. Thus, differences in tetramer staining intensity may indicate the presence of functionally different types of T cells 17;18 .
The dominant presence of minor H antigen-specific alloimmune T REG or T CTL in a hematopoietic stem cell (SC) graft may have differential impacts on the outcome of HLA identical minor H antigen non-identical SCT. As a first step towards understanding how the minor H antigen allo immunization status of SC donors may affect SCT outcome, we analyzed whether 'natural' exposure to fetal or maternal minor H allo antigens induces functionally different T cells in healthy parous female and male blood donors respectively. Regarding the latter donors, only first born sons were selected thereby avoiding any confounding effects of transmaternal transfer of earlier born sibling cells 19 .
Peripheral Blood Mononuclear Cells (PBMC) from selected minor H antigen mismatched mother-child pairs were collected and a detailed analysis on the presence of minor H antigen-specific T CTL and T REG was performed.
MATERIALS AND METHODS

Study participants
Familial allo-immunization to the HLA-A2 restricted minor H antigens HA-1, HA-2, HA-8
and HY 20 was studied (Table 1) . Donors with a history of blood transfusion were excluded from the analysis 21 . pooled human serum, 1% phytohemagglutinin and 150 IU/ml recombinant IL-2.
Functional assays
The cytolytic capacity was tested in a standard chromium release assay. In brief, 2500
51
Cr labeled target cells were incubated with serial dilutions of T cells as indicated in the figures. Supernatants were harvested after 4 hour of incubation for gamma counting.
Percentage specific lysis was calculated as follows: (experimental release -spontaneous release)/(maximal release -spontaneous release) x 100%. The data are shown as the mean of duplicate samples. . 
RESULTS
Isolation, expansion and functional testing of total tetramer-binding fractions obtained from female and male blood donors.
We earlier described the usefulness of HLA-A2/minor H peptide tetramers to visualize 22 and isolate minor H antigen-specific CD8 pos T CTL from peripheral blood cells for subsequent functional analyses after polyclonal expansion 3;26 . The latter protocol was used to study the presence of T CTL within total tetramer-binding fractions isolated from 10 female donors with minor H antigen HY or HA-1 mismatched offspring and from 6 HA-1 pos male donors, i.e. first born sons, all delivered by an HA-1 pos mother. The minor H genotypes of these mother/offspring combinations are listed in Table 1 Male donor analyses: HA-1 A2 (♂1-♂5) or HA-2 A2 (♂6) tetramer pos populations were isolated, as exemplified in Figure 2C , and cultured as described for the female donors.
T CTL outgrowth occurred in 3 out of 6 cases (Table 3) . Functional testing revealed the presence of natural ligand-specific T CTL in CD8 pos populations obtained from donor ♂1
( Figure 2D , bottom plot). Peptide-specific T CTL were present in CD8 pos populations generated from donor ♂3 ( Figure 2D , upper plot) and ♂5 (data not shown).
Collectively, these experiments show that minor H antigen-specific T CTL can be identified in approximately half of the analyzed female and male donors.
Minor H antigen-specific T cells with a suppressive function identified in mothers and in first born sons.
We next questioned whether failure to expand T CTL from total tetramer pos fractions, as observed in the other half of female and male donors tested, could be due to the copresence of minor H antigen-specific T REG . The tvDTH assay was applied to analyze the putative presence of minor H antigen-specific T REG within total PBMC 17 . These PBMC were derived from the same blood sample as used for the identification of minor H antigen-specific T CTL . Sixteen blood donors, 9 females and 7 males, were selected for these experiments (Table 3 ). Figure 3 shows the data of two mothers with male offspring, representing either the tvDTH regulator phenotype (♀4, left graph), indicating the presence of functional minor H antigen-specific T REG , or the tvDTH non-regulator phenotype (♀7, right graph), indicating the absence of functional minor H antigenspecific T REG . Four out of nine mothers (44%) were classified as a tvDTH regulator; the remaining five mothers (55%) as tvDTH non-regulators. The latter group included the two females with HA-1 disparate offspring (♀10 and 11). Thus, natural exposure of mothers to fetal inherited minor H alloantigens seems to lead to either sensitization or tolerization to minor H alloantigens.
Likewise, five HA-1 neg sons, all delivered by a HA-1 pos mother, were tested in the tvDTH assay (Table 3) . Only one donor (♂1) could be assigned as a tvDTH non-regulator. Figure 4B , right panel). Both dual and predominantly tetramer dim staining profiles were also found in the two mothers with HA-1 mismatched offspring respectively (Table 4) . Collectively, dual tetramer bright and tetramer dim staining T cells are observed in five out of a total of nine women analyzed in this study.
Predominantly tetramer dim staining T were observed in the four remaining women.
Likewise, PBMC from six male donors were analyzed for the presence of HA-1 A2 or HA-2 A2 tetramer bright and/or dim staining T cells (Table 4 ). Four out of six males predominantly displayed tetramer dim staining T cells. A representative example is depicted in Figure 4D , right panel illustrating the ratio of 1:16 bright:dim staining T cells as observed in male donor 2. Donors ♂1 ( Figure 4D , left panel) and ♂4 displayed dual tetramer bright and tetramer dim staining T cells ( Figure 5A ), followed by ♀8 (12% and 13% respectively), ♀6 ( Figure 5A ) and ♀9 (both 1%). HA-1 A2 tetramer dim staining T cells expressing CD25 and CTLA-4 were also detected in the two male donors analyzed.
Whereas donor ♂4 only displayed very low numbers of CD25 and CTLA-4 positive cells (both 1%), higher numbers of this phenotype were detected in donor ♂5 ( Figure 5A ).
Neither 
Minor H antigen-mediated regulation involves CTLA-4.
We next questioned whether CTLA-4 expressed by minor H antigen-specific tetramer . Although further studies are necessary to determine the effect of more than one pregnancy on the maternal allo-immunization status, the in this study observed T cell heterogeneity may provide a first clue why donor parity is still a controversial factor affecting HLA identical SCT outcome. Indeed, unequivocal conclusions regarding the effect of donor parity on the Graft-versus-Host Disease (GvHD) risk still exist as reviewed 33 . Interestingly, in eight out of nine females analyzed, a correlation was found between their tvDTH test result, which was generated ex vivo in a blinded fashion, and the outcome of the in parallel performed in vitro experiments on T CTL outgrowth ( Table 3) . Dissection of tolerized donors from sensitized donors may also be useful in male-to-male SCT settings.
Because of the presumed lowest GvHD risk, an HLA identical male donor is considered as the optimal SC donor for male patients 33 . The same pair. 4 The autosomal minor H alloantigen under study is indicated in bold. HY is studied in female donors in case no autosomal minor H mismatch exists between the mother and her offspring. The dominant presence of minor H alloantigen-specific Treg within total PBMC was measured in the tvDTH assay 17 . The percentages indicate that percentage inhibition of recall antigen-induced swelling footpad responses in the presence of the relevant minor H allo peptide; ND not determined. The ratio tetramer bright : tetramer dim is 1 : >10. 
